Mark E. Hooper

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Vascular Pharmaceuticals, Inc. develops and commercializes therapeutics for the treatment of diabetics. It provides new treatment options to individuals living with diabetic complications such as nephropathy. The company was founded by David R. Clemmons and Laura Maile in 2005 and is headquartered in Research Triangle Park, NC.

Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.

Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA.

New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA.

Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA.

Artizan Biosciences, Inc. engages in the provision of healthcare services. It develops curative treatments for inflammatory diseases. The company was founded by Richard A. Flavell, Noah W. Palm and Marcel R. de Zoete and is headquartered in New Haven, CT.

Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA.

Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada.

Founded in 1999 by Dr. Ron Weiss and Jeff Joseph, Prescient Capital Partners is a venture capital/private equity firm located in Berwyn, Illinois. In 2007, the firm formed Prescient Advisors to provide strategic consulting services to assist entrepreneurs and CEOs of start-up, emerging and established companies in accessing resources needed to grow their businesses.

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

BIOS Capital Management LP (BIOS Partners) is a venture capital firm founded in 2014 by Stella Robertson, Aaron Fletcher and Leslie Kreis. The firm is headquartered in Fort Worth, Texas.

Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA.

AyuVis Research, Inc. engages in the provision of pharmaceutical services. The company was founded by Suchi Acharya and Gagan Acharya in 2014 and is headquartered in Fort Worth, TX.

Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX.

Encore Vision, Inc. develops novel treatment in presbyopia. The company is headquartered in Fort Worth, TX.

Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York.

Pinstripes, Inc. is an experiential dining and entertainment company that offers a combination of made-from-scratch dining, bowling, and bocce, as well as flexible private event space. Pinstripes has 13 locations across the United States, including Northbrook, South Barrington, Oak Brook, and Chicago, IL; Edina, MN; Georgetown and Bethesda, MD; Cleveland, OH; Norwalk, CT; and San Mateo, CA. The company's elegant and spacious venues can accommodate groups of 20 to 1,500 people for private events, parties, and celebrations. Pinstripes has plans for significant further expansion, with five additional venues scheduled to open in 2022. The company was founded in 2007 and is headquartered in Northbrook, IL. Dale Schwartz founded the company in 2007 and has been the CEO since then.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

VHS of Illinois provides healthcare services to communities throughout the northwest and southwest suburbs of Chicago. Its services include bariatrics, cancer care, heart and vascular care, hospice care, imaging and radiology, orthopedics, pain management, psychiatry and behavioral health, rehabilitation, urology, and women’s health services. The company was founded in 1919 and is headquartered in Berwyn, IL.

EyeCare Services Partners Holdings LLC provides ophthalmologic and optometric services. The company was founded in May 2014 and is headquartered in Dallas, TX.

Cellview Imaging, Inc. develops and commercializes ophthalmic imaging devices. It provides multispectral, hyperspectral, metabolic Imaging, and optical coherence tomography. The company is headquartered in Toronto, Canada.

2C Tech Corp. develops a medical device based on nanotechnology. It offers SeeQ device, which involves intraocularly delivered photoactive nanoparticles that converts light to electrical energy similar to a conventional solar cell but on a sub-cellular scale. The company is headquartered in Irvine, CA.

Re-Vana Therapeutics Ltd. is a specialty ocular therapeutic and British drug delivery company that focuses on developing its internal pipeline and external strategic collaborations to advance its novel drug delivery platform. In 2022, Re-Vana won the Ophthalmic Innovation Summit Retina Award in drug delivery and the Belfast Nth Ireland Chamber 2022 Award for Business Innovation. Re-Vana Therapeutics was founded in 2016 as a spin-out from Queen's University, with the main office located in Belfast, UK, and an office, Re-Vana Therapeutics, Inc., based elsewhere. The company has raised more than $17.75m to support the development of sustained release biologics. In 2019, Re-Vana secured funding from Innovate totaling more than $400k to support the development of a sustained release drug. Additionally, in 2020, the company entered into a strategic feasibility collaboration with a leading pharmaceutical company for a novel therapeutic.

Visibly, Inc. develops a platform to perform an online eye exam. It operates as a healthcare technology firm that offers the convenient and affordable way to get a prescription for glasses and contacts. The firm’s technology provides valid glasses and contact lens prescriptions online from the convenience of home. The company was founded by Aaron Dallek and Steven Lee in 2012 and is headquartered in Chicago, IL.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.

Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI.

Part of Thermo Fisher Scientific, Inc., Phadia US, Inc. engages in the research and development of blood testing products and instrumentation that aid in the diagnosis of allergy. The company is based in Portage, MI.